The House today approved the final version of virus relief reconciliation legislation (H.R. 1319), clearing the bill for the president's signature. It passed on a partisan 220-211 tally. No Republicans voted for the bill. Rep. Jared Golden (D-ME) was the only Democrat to vote against it. 

The $1.9 trillion bill, which previously cleared the Senate last weekend, will be signed into law on Friday, the White House says.

The bill includes a number of tax policy changes affecting businesses. See this previously issued Tax Flash for more on these provisions.

• 627-page text of the final version of the legislation
• Title-by-title summary of the bill issued by Senate Democrats
• Summary of Senate changes made to the bill issued by Senate Democrats
• Fact sheet issued by House Speaker Nancy Pelosi (D-CA)
• Joint Committee on Taxation revenue estimate of the tax provisions in the bill
• Congressional Research Service report on the bill's tax provisions

Miller & Chevalier Coronavirus Task Force
The outbreak of COVID-19 is creating significant business and legal challenges for companies throughout the world. In response to client demand, the firm has formed an interdisciplinary task force to help businesses navigate these issues.

COVID-19 Resource Library
We also maintain a resource library of legislative responses and regulatory guidance related to COVID-19.

The information contained in this communication is not intended as legal advice or as an opinion on specific facts. This information is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. For more information, please contact one of the senders or your existing Miller & Chevalier lawyer contact. The invitation to contact the firm and its lawyers is not to be construed as a solicitation for legal work. Any new lawyer-client relationship will be confirmed in writing.

This, and related communications, are protected by copyright laws and treaties. You may make a single copy for personal use. You may make copies for others, but not for commercial purposes. If you give a copy to anyone else, it must be in its original, unmodified form, and must include all attributions of authorship, copyright notices, and republication notices. Except as described above, it is unlawful to copy, republish, redistribute, and/or alter this presentation without prior written consent of the copyright holder.